Substance / Medication

D-alpha-tocopherol

Overview

Active Ingredient
alpha tocopherol
RxNorm CUI
237099

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Vitamin E supplementation in people with cystic fibrosis: A Cochrane review summary.
Dru Riddle J · Int J Nurs Stud · 2019
PMID: 29954583Meta-Analysis
Vitamin E supplementation in people with cystic fibrosis.
Okebukola Peter O, Kansra Sonal, Barrett Joanne · Cochrane Database Syst Rev · 2017
PMID: 28262916Meta-AnalysisFull text (PMC)
Vitamin E supplementation in people with cystic fibrosis.
Okebukola Peter O, Kansra Sonal, Barrett Joanne · Cochrane Database Syst Rev · 2014
PMID: 25489958Meta-Analysis
Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trials.
Suksomboon N, Poolsup N, Sinprasert S · J Clin Pharm Ther · 2011
PMID: 21198720Meta-Analysis
Risk of inadequate intakes of vitamins A, B1, B6, C, E, folate, iron and calcium in the Spanish population aged 4 to 18.
Serra-Majem L, Ribas L, Ngo J et al. · Int J Vitam Nutr Res · 2001
PMID: 11840835Meta-Analysis
Rectal administration of d-alpha tocopherol for active ulcerative colitis: a preliminary report.
Mirbagheri Seyed-Amir, Nezami Behtash-Ghazi, Assa Solmaz et al. · World J Gastroenterol · 2008
PMID: 18932276TrialFull text (PMC)
Ultraviolet B-induced DNA damage in human epidermis is modified by the antioxidants ascorbic acid and D-alpha-tocopherol.
Placzek Marianne, Gaube Sabine, Kerkmann Urs et al. · J Invest Dermatol · 2005
PMID: 15675947Trial
UVB photoprotection with antioxidants: effects of oral therapy with d-alpha-tocopherol and ascorbic acid on the minimal erythema dose.
Mireles-Rocha Homero, Galindo Ignacio, Huerta Miguel et al. · Acta Derm Venereol · 2002
PMID: 12013192Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
D-alpha-tocopherol (substance)
SNOMED CT
116776001
UMLS CUI
C0969677
RxNorm CUI
237099

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.